article thumbnail

Eli Lilly releases topline data for new oral GLP-1

European Pharmaceutical Review

“ ACHIEVE-1 is the first of seven Phase III studies examining the safety and efficacy of orforglipron across people with diabetes and obesity. This demonstrates promising potential for patients, as seven percent is regarded as the diabetes threshold by the American Diabetes Association’s (ADA).

article thumbnail

Therapeutic Guidelines, Australian Medicines Handbook and APF

RX Note

AMH Aged Care Companion - Contains information on managing more than 70 common conditions in the elderly, with a focus on issues relevant to older people using medicines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Beauty, boosters and the law: Who’s watching India’s wellness market?

Express Pharma

In the oral form, as a supplement, Glutathione should be consumed only in the recommended dosage prescribed by a doctor. Doctors have stated that the danger of getting these treatments from non-professionals could give rise to wrong dosage, faulty technique, or contamination.

Labelling 105
article thumbnail

Pharma Marketing AI: Doing More With More

Pharma Marketing Network

help teams generate draft copy, A/B test headlines, and adapt content across therapeutic areas—whether it’s for Dupixent in dermatology or Ozempic in diabetes care. Even at the campaign planning stage, generative AI tools like ChatGPT or Copy.ai Moreover, AI enhances segmentation.

HIPAA 52
article thumbnail

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

Fixed-dose combinations (FDCs), which contain two or more active ingredients in a single dosage form, have seen a significant rise in production and usage across the pharmaceutical industry. Amlodipine + Telmisartan, Atorvastatin + Ezetimibe) Diabetes management formulations for glycemic control (e.g.,

article thumbnail

The promise and perils of weight loss drugs

Express Pharma

This is apparently to support dosage adjustment in the initial three weeks without additional financial impact. However, the two drugs are not directly comparable in terms of dosage levels. While this battle will be an interesting chase, it has serious implications for the millions of Indians who struggle with weight loss and diabetes.

Dosage 102
article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

Related Videos Related Content Advertisement June 27th 2025 Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP Luke Halpern, Assistant Editor June 3rd 2025 S2.